Azitra Inc. AZTR 深 滬
等待開盤 03-26 09:30:00 美东时间
0.2528
-0.021
-7.84%
華盛通- 最 高0.286
- 今 開0.2564
- 成交量 799.67万股
- 最 低 0.235
- 昨 收 0.2743
- 總市值 409.34万
- 52周最高 2.664
- 市盈率 靜 --
- 換手率 49.39%
- 52周最低 0.10
- 委 比 66.67%
- 總股本 1619.24万
- 歷史最高 1034.964
- 量 比 0.06
- 振 幅 18.59%
- 歷史最低 0.10
- 每 手 1
- 風險率 0.69%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why Are Shares Of Azitra Rising?
Azitra shares are trading higher Friday after announcing $10.5 million in private placement, with potential for additional $20.9 million.
03-21 01:09
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Azitra (AMEX:AZTR) stock rose 52.6% to $0.27 during Friday's regular s...
03-21 01:06
Azitra Inc. (AZTR) Surges Over 44% After Hours— Here's Why It's Trending
Azitra shares jumped over 44% in after-hours trading following a $31.4 million financing deal to advance its filaggrin protein and peptide platform.
03-20 12:26
Azitra Enters SPA With New And Existing Investors, Secures Up To $31.4M In Convertible Preferred Stock And Warrants To Launch Innovative Protein And Peptide Research For Cosmetic And Cosmeceutical Markets
Initial funding of approximately $10.5MM in convertible preferred stock and up to an additional $20.9MM upon cash exercise of warrantsFinancing marks launch of Azitra new innovative protein and peptide research programs
03-20 01:16
Azitra Faces NYSE American Noncompliance and Delisting Risk
Azitra Inc ( ($AZTR) ) has provided an update. Azitra Inc., a clinical-stage bi...
03-14 05:49
Azitra Receives Noncompliance Notice From NYSE
Azitra, Inc. (NYSE:AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced it received a notice from the staff of NYSE American LLC (the
03-14 05:18
Azitra Cancels Special Stockholder Meeting and Proposals
Azitra Inc ( ($AZTR) ) has shared an announcement. Azitra Inc., a clinical-stag...
03-06 06:14
Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders
BRANFORD, Conn., March 5, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR) ("Azitra" or the "Company"), a clinical stage biopharmaceutical company focused on developing innovative the...
03-06 05:30
Watching Azitra; Zacks Small-Cap Research Gives Stock $1.70/Share Price Valuation
https://s27.q4cdn.com/906368049/files/News/2026/Zacks_SCR_Research_02042026_AZTR_Vandermosten.pdf
03-04 23:31
Anitra Q4 EPS $(0.81) Misses $(0.33) Estimate
Anitra (AMEX:AZTR) reported quarterly losses of $(0.81) per share which missed the analyst consensus estimate of $(0.33) by 149.23 percent. This is a 61.06 percent increase over losses of $(2.08) per share from the same
02-28 06:38
